849 related articles for article (PubMed ID: 19544393)
1. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.
Zengin E; Sarper N
Pediatr Blood Cancer; 2009 Dec; 53(6):967-72. PubMed ID: 19544393
[TBL] [Abstract][Full Text] [Related]
2. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
[TBL] [Abstract][Full Text] [Related]
3. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
4. Revaccination of children after completion of standard chemotherapy for acute leukemia.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):635-42. PubMed ID: 17278052
[TBL] [Abstract][Full Text] [Related]
5. Humoral immune response after post-chemotherapy booster diphtheria-tetanus-pertussis vaccine in pediatric oncology patients.
Cheng FW; Leung TF; Chan PK; Lee V; Shing MK; Chik KW; Yuen PM; Li CK
Pediatr Blood Cancer; 2009 Feb; 52(2):248-53. PubMed ID: 18937325
[TBL] [Abstract][Full Text] [Related]
6. Avidity of tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia - implications for vaccination strategies.
Ek T; Mellander L; Hahn-Zoric M; Abrahamsson J
Acta Paediatr; 2006 Jun; 95(6):701-6. PubMed ID: 16754551
[TBL] [Abstract][Full Text] [Related]
7. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E
Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809
[TBL] [Abstract][Full Text] [Related]
8. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
McCusker C; Somerville W; Grey V; Mazer B
Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
[TBL] [Abstract][Full Text] [Related]
9. Lack of serologic immunity against vaccine-preventable diseases in children after thoracic transplantation.
Urschel S; Cremer S; Birnbaum J; Dallapozza R; Fuchs A; Jäger G; Schmitz C; Belohradsky BH; Netz H
Transpl Int; 2010 Jun; 23(6):619-27. PubMed ID: 20028497
[TBL] [Abstract][Full Text] [Related]
10. Immunity to diphtheria, pertussis, tetanus, and poliomyelitis in children with acute lymphocytic leukemia after cessation of chemotherapy.
van der Does-van den Berg A; Hermans J; Nagel J; van Steenis G
Pediatrics; 1981 Feb; 67(2):222-9. PubMed ID: 6941208
[TBL] [Abstract][Full Text] [Related]
11. Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA.
Groves FD; Gridley G; Wacholder S; Shu XO; Robison LL; Neglia JP; Linet MS
Br J Cancer; 1999 Sep; 81(1):175-8. PubMed ID: 10487630
[TBL] [Abstract][Full Text] [Related]
12. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051
[TBL] [Abstract][Full Text] [Related]
13. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
Nordøy T; Husebekk A; Aaberge IS; Jenum PA; Samdal HH; Flugsrud LB; Kristoffersen AC; Holte H; Kvaløy S; Kolstad A
Bone Marrow Transplant; 2001 Oct; 28(7):681-7. PubMed ID: 11704791
[TBL] [Abstract][Full Text] [Related]
14. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia.
Ercan TE; Soycan LY; Apak H; Celkan T; Ozkan A; Akdenizli E; Kasapçopur O; Yildiz I
J Pediatr Hematol Oncol; 2005 May; 27(5):273-7. PubMed ID: 15891564
[TBL] [Abstract][Full Text] [Related]
15. Humoral immunity against hepatitis B, tetanus, and diphtheria following chemotherapy for hematologic malignancies: a report and review of literature.
Alavi S; Rashidi A; Arzanian MT; Shamsian B; Nourbakhsh K
Pediatr Hematol Oncol; 2010 Apr; 27(3):188-94. PubMed ID: 20367262
[TBL] [Abstract][Full Text] [Related]
16. The immunological response of Thai infants to haemophilus influenzae type B polysaccharide-tetanus conjugate vaccine co-administered in the same syringe with locally produced diphtheria-tetanus-pertussis vaccine.
Kerdpanich A; Hutagalung Y; Watanaveeradej V; Bock HL; Steinhoffmd M
J Med Assoc Thai; 2007 Jul; 90(7):1330-6. PubMed ID: 17710973
[TBL] [Abstract][Full Text] [Related]
17. Antibody response after measles immunization.
Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
[TBL] [Abstract][Full Text] [Related]
18. A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation.
Parkkali T; Käyhty H; Hovi T; Olander RM; Roivainen M; Volin L; Ruutu T; Lahdenkari M; Ruutu P
Bone Marrow Transplant; 2007 Feb; 39(3):179-88. PubMed ID: 17211432
[TBL] [Abstract][Full Text] [Related]
19. Pediatric disease burden and vaccination recommendations: understanding local differences.
Gentile A; Bhutta Z; Bravo L; Samy AG; Garcia RD; Hoosen A; Islam T; Karimi A; Salem M; Simasathien S; Sohail A; Watanaveeradej V; Wiedenmayer K; Schmitt HJ
Int J Infect Dis; 2010 Aug; 14(8):e649-58. PubMed ID: 20181506
[TBL] [Abstract][Full Text] [Related]
20. Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens.
Brodtman DH; Rosenthal DW; Redner A; Lanzkowsky P; Bonagura VR
J Pediatr; 2005 May; 146(5):654-61. PubMed ID: 15870670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
